Gradium Raises $100M Seed Round Backed by Nvidia to Expand Voice AI Platform

Gradium, a Paris-based voice AI startup, has reopened its seed round to new investors, including Nvidia, bringing its total funding to $100 million. The company plans to use the capital to open an office in the Bay Area, positioning itself closer to major AI labs including Anthropic, Google, Meta, and OpenAI.

Gradium launched out of stealth in December with $70 million from investors including FirstMark Capital, Eurazeo, DST Global Partners, Eric Schmidt, and French telecom entrepreneur Xavier Niel. The company was spun out of French AI research lab Kyutai, which Niel also backs, and was co-founded by Neil Zeghidour, a researcher with prior experience at Google Brain, DeepMind, and Facebook.

Gradium’s technology focuses on delivering voice AI with ultra-low latency, aiming to eliminate the delays that often disrupt conversations with AI voice agents. The company faces competition from other voice AI players, including ElevenLabs, valued at $11 billion earlier this year, as well as major model developers like Google’s Gemini. Despite this competition, Gradium said it has secured significant customers since its December launch, including French automaker Renault.

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

Atom and NSK Announce Strategic Partnership to Help Develop the Humanoid Robot Industry in Japan

Insider Brief Atom and NSK have signed a memorandum of understanding to jointly develop and test components and AI systems in Japan to bolster domestic

Impossible Metals Reports its Eureka II Recovers Itself From the Ocean, Fully Autonomously

Insider Brief Impossible Metals has reported its Eureka II subsea vehicle completed an autonomous offshore recovery demonstration, locating and reconnecting with its surface vessel without

gloved hands drawing vaccine from vial with syringe
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery

Insider Brief PRESS RELEASE — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the launch of the Open

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape